To access the full text documents, please follow this link: http://hdl.handle.net/10256/7496

Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity
Xifró Collsamata, Xavier; Anglada-Huguet, Marta; Rué, Laura; Saavedra, Ana; Pérez-Navarro, Esther; Alberch i Vié, Jordi
Background: The 90-kDa ribosomal S6 kinase (Rsk) family is involved in cell survival. Rsk activation is regulated bysequential phosphorylations controlled by extracellular signal-regulated kinase (ERK) 1/2 and 3 phosphoinositidedependent protein kinase 1 (PDK1). Altered ERK1/2 and PDK1 phosphorylation have been described in Huntington’s disease (HD), characterized by the expression of mutant huntingtin (mhtt) and striatal degeneration. However, the role of Rsk in this neurodegenerative disease remains unknown. Here, we analyzed the protein levels, activity and role of Rsk in in vivo and in vitro HD models. Results: We observed increased protein levels of Rsk1 and Rsk2 in the striatum of HdhQ111/Q111 and R6/1 mice, STHdhQ111/Q111 cells and striatal cells transfected with full-length mhtt. Analysis of the phosphorylation of Rsk in Hdh mice and STHdh cells showed reduced levels of phospho Ser-380 (dependent on ERK1/2), whereas phosphorylation at Ser-221 (dependent on PDK1) was increased. Moreover, we found that elevated Rsk activity in STHdhQ111/Q111 cells was mainly due to PDK1 activity, as assessed by transfection with Rsk mutant constructs. The increase of Rsk in STHdhQ111/Q111 cells occurred in the cytosol and in the nucleus, which results in enhanced phosphorylation of both cytosolic and nuclear Rsk targets. Finally, pharmacological inhibition of Rsk, knock-down and overexpression experiments indicated that Rsk activity exerts a protective effect against mhtt-induced cell death in STHdhQ7/Q7 cells transfected with mhtt. Conclusion: The increase of Rsk levels and activity would act as a compensatory mechanism with capacity to prevent mhtt-mediated cell death. We propose Rsk as a good target for neuroprotective therapies in HD
Corea de Huntington (Malaltia)
Huntington 's chorea
Cervell -- Malalties
Brain -- Diseases
Attribution 2.0 Spain
http://creativecommons.org/licenses/by/2.0/es/
Article
info:eu-repo/semantics/publishedVersion
BioMed Central
         

Show full item record

Related documents

Other documents of the same author

Saavedra, Ana; Giralt, A.; Rué, Laura; Xifró Collsamata, Xavier; Xu, J.; Ortega, Z.; Lucas, J.J.; Lombroso, P.J.; Alberch i Vié, Jordi; Pérez-Navarro, Esther
Xifró Collsamata, Xavier; Vidal Sancho, Laura; Boadas Vaello, Pere; Turrado, Carlos; Alberch i Vié, Jordi; Puig Miquel, Teresa; Verdú Navarro, Enrique
Xifró i Collsamata, Xavier; Anglada Huguet, Marta; Rue, Laura; Saavedra, Ana; Pérez Navarro, Esther; Alberch i Vié, Jordi
Saavedra, Ana; Giralt Torroella, Albert; Arumí, Helena; Alberch i Vié, Jordi; Pérez Navarro, Esther
Arenas, Ernest; Alberch i Vié, Jordi; Pérez Navarro, Esther; Solsona Sancho, Carles; Marsal Tebé, Jordi
 

Coordination

 

Supporters